D-葡萄糖醛酸 | 70021-34-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: D-葡萄糖醛酸
• 英文名称: D-glucuronic acid
• 英文别名: α-D-glucopyranosyluronic acid；α-D-glucopyranuronic acid；glucronic acid, α-anomer；α-D-glucuronic acid；α-glucuronic acid；glucuronic acid；alpha-D-glucopyranuronic acid；(2S,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid
• CAS: 70021-34-0
• 化学式: C₆H₁₀O₇
• 分子量: 194.141
• InChiKey: AEMOLEFTQBMNLQ-WAXACMCWSA-N

物化性质

• 熔点：
  163-164 °C(Solv: ethanol (64-17-5); benzene (71-43-2))
• 沸点：
  495.2±45.0 °C(Predicted)
• 密度：
  1.987±0.06 g/cm3(Predicted)
• 物理描述：
  Solid
• 溶解度：
  485 mg/mL

计算性质

• 辛醇/水分配系数(LogP)：
  -2.3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  127
• 氢给体数：
  5
• 氢受体数：
  7

安全信息

• 储存条件：
  2-8°C

反应信息

• 作为反应物：
  描述：

  D-葡萄糖醛酸 在 sodium hydroxide 、 N-bromo-p-toluenesulfonamide 、 sodium perchlorate 作用下， 以 水 为溶剂， 反应 24.0h， 生成 葡糖二酸
  参考文献：
  名称：

  KINETIC AND MECHANISTIC INVESTIGATION OF OXIDATION OF URONIC ACIDS BY SODIUM N-BROMOARYLSULFONAMIDES IN ALKALINE MEDIUM

  摘要：

  The kinetics of oxidation of uronic acids (UAs), D-glucuronic acid and D-bromo-p-toluenesulfonamide or bromamine-T galacturonic acid, by sodium N (BAT) and sodium N-bromobenzenesulfonamide or bromamine-B (BAB) in alkaline medium at 30degreesC have been investigated and the rate law, rate = k [OX] [UA] [HO-] where [OX] [BAT] or [BAB] was observed. The product p-toluenesulfonamide (PTS) or benzenesulfonamide (BSA) and ionic strength have no influence on the rate. The rate decreased when the dielectric constant (epsilon) of the medium was decreased. The rate increased in D2O medium. Proton inventory studies were made in D2O-H2O mixtures. Effect of temperature was studied and from the Arrhenius plots, activation parameters were computed. A mechanism involving the formation of enediol anion, which reacts with positive bromine of the bromamine in the rate-limiting step is suggested.

  DOI：

  10.1081/car-120016848
• 作为产物：
  描述：

  (1S,2S)-安非他酮N-1’-脱氧-beta-D-葡萄糖醛酸 以 氘代二甲亚砜 为溶剂， 反应 24.0h， 以50%的产率得到D-葡萄糖醛酸
  参考文献：
  名称：

  A new synthesis ofD-glycosiduronates from unprotectedD-uronic acids

  摘要：

  在THF中对完全未保护的D-半乳糖醛酸1进行O-糖苷化，在BF3·OEt2的促进下得到α-吡喃苷4a，而在FeCl3存在下得到β-呋喃苷6β；当对D-葡糖醛酸2或“D-葡糖醛”3进行相同反应时，合成了优良收率和高β选择性的烷基-D-葡萄呋喃糖醇酸内酯7。

  DOI：

  10.1039/c39950001391

文献信息

• [EN] IMPROVED SYNTHETIC METHODS OF MAKING (2H-1,2,3-TRIAZOL-2-YL)PHENYL COMPOUNDS AS OREXIN RECEPTOR MODULATORS<br/>[FR] PROCÉDÉS SYNTHÉTIQUES AMÉLIORÉS POUR LA FABRICATION DE COMPOSÉS DE (2H-1,2,3-TRIAZOL-2-YL)PHÉNYLE UTILISÉS COMME MODULATEURS DES RÉCEPTEURS DE L'OREXINE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2021023843A1

  公开（公告）日：2021-02-11

  Processes for preparing (((3aR,6aS)-5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-l,2,3-triazol-2- yl)phenyl)methanone are described, which are useful for commercial manufacturing. Said compound is an orexin receptor modulator and may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia and depression.

  描述了制备(((3aR,6aS)-5-(4,6-二甲基嘧啶-2-基)己氢吡咯[3,4-c]吡咯-2(1H)-基)(2-氟-6-(2H-1,2,3-三唑-2-基)苯基)甲酮的过程，这对于商业生产是有用的。所述化合物是一种促进睡眠素受体的调节剂，可能在制药组合物和治疗由促进睡眠素活性介导的疾病状态、紊乱和症状，如失眠和抑郁症的方法中是有用的。
• Method of producing conjugate vaccines
  申请人：Finn Nicholas

  公开号：US20080213297A1

  公开（公告）日：2008-09-04

  The present invention relates to a method of production of a hydrazide modified sugar comprising a step of reacting a sugar with a hydrazide in a reaction solvent at a pH of between 3 and 5.5, wherein the solvent comprises an aqueous based solvent and an optional polar organic co-solvent. A further aspect of the invention relates to a method of production of a polysaccharide epitope carrier protein conjugate comprising the steps of: (a) reacting a polysaccharide epitope with a hydrazide to form a hydrazide modified polysaccharide epitope; (b) reacting the hydrazide modified polysaccharide epitope with a linker that has been pre-coupled to a carrier protein. Another aspect of the invention relates to a method of production of a sugar-dihydrazide-aldehyde adduct comprising the steps of: (a) producing a hydrazide modified sugar using a method according to the invention, wherein the hydrazide modified sugar includes a further unreacted hydrazide moiety; and (b) reacting the further hydrazide moiety with the aldehyde functionality of a linker group.

  本发明涉及一种生产含有肼改性糖的方法，包括在反应溶剂中将糖与肼在pH值在3至5.5之间反应的步骤，其中溶剂包括水基溶剂和可选的极性有机共溶剂。该发明的另一个方面涉及一种生产多糖表位载体蛋白共轭物的方法，包括以下步骤：(a)将多糖表位与肼反应，形成肼改性多糖表位；(b)将肼改性多糖表位与预先偶联到载体蛋白上的连接剂反应。该发明的另一个方面涉及一种生产糖-二肼-醛加合物的方法，包括以下步骤：(a)使用根据本发明的方法生产肼改性糖，其中肼改性糖包括进一步未反应的肼基团；(b)将进一步的肼基团与连接剂基团的醛功能基团反应。
• [EN] CYCLIC PHOSPHATE COMPOUNDS<br/>[FR] COMPOSÉS DE PHOSPHATE CYCLIQUE
  申请人：LIGAND PHARM INC

  公开号：WO2020219464A1

  公开（公告）日：2020-10-29

  Provided herein are cyclic phosphate compounds, their preparation and their uses, such as treating liver diseases or conditions or a disease or condition in which the physiological or pathogenic pathways involve the liver.

  本文提供了环磷酸酯化合物，它们的制备以及它们的用途，例如用于治疗肝脏疾病或病况，或者涉及肝脏的生理或病理途径的疾病或病况。
• [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2015180612A1

  公开（公告）日：2015-12-03

  Disclosed are novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

  揭示了新型视黄醇相关孤儿受体γ（RORγ）调节剂及其在通过RORγ介导的疾病治疗中的应用。
• [EN] A CONJUGATE OF A CYTOTOXIC AGENT TO A CELL BINDING MOLECULE WITH BRANCHED LINKERS<br/>[FR] CONJUGUÉ D'UN AGENT CYTOTOXIQUE À UNE MOLÉCULE DE LIAISON CELLULAIRE AVEC DES LIEURS RAMIFIÉS
  申请人：HANGZHOU DAC BIOTECH CO LTD

  公开号：WO2020257998A1

  公开（公告）日：2020-12-30

  Provided is a conjugation of cytotoxic drug to a cell-binding molecule with a side-chain linker. It provides side-chain linkage methods of making a conjugate of a cytotoxic molecule to a cell-binding ligand, as well as methods of using the conjugate in targeted treatment of cancer, infection and immunological disorders.

  提供了一种将细胞毒性药物与一个侧链连接分子结合的共轭物。它提供了制备细胞毒性分子与细胞结合配体的共轭物的侧链连接方法，以及在靶向治疗癌症、感染和免疫性疾病中使用该共轭物的方法。